SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014 Report

[March 03, 2014]

Research and Markets: Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014 Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/c8bdzr/systemic_juvenile) has announced the addition of the "Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014" report to their offering.

'Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA).

Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Scope

- A snapshot of the global therapeutic scenario for Systemic Juvenile Idiopathic Arthritis (SJIA).

- A review of the Systemic Juvenile Idiopathic Arthritis (SJIA) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Systemic Juvenile Idiopathic Arthritis (SJIA) pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Systemic Juvenile Idiopathic Arthritis (SJIA) Overview

Pipeline Products for Systemic Juvenile Idiopathic Arthritis (SJIA) - Overview

Late Stage Products

Clinical Stage Products

Early Stage Products

Systemic Juvenile Idiopathic Arthritis (SJIA) - Products under Development by Companies

Systemic Juvenile Idiopathic Arthritis (SJIA) - Therapeutics Assessment

Drug Profiles

abatacept - Drug Profile

golimumab - Drug Profile

givinostat - Drug Profile

etanercept biosimilar - Drug Profile

adalimumab biosimilar - Drug Profile

Systemic Juvenile Idiopathic Arthritis (SJIA) - Recent Pipeline Updates

Featured News & Press Releases

Appendix

Companies Mentioned

Bristol-Myers Squibb Company

Johnson & Johnson

Biocon Limited

Italfarmaco S.p.A.

Avesthagen Limited

For more information visit http://www.researchandmarkets.com/research/c8bdzr/systemic_juvenile

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.